Nanobiotix S.A. (NBTX) vs First Tracks Biotherapeutics (TRAX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Nanobiotix S.A. is the larger company by market cap ($1.17 billion vs $1.14 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NBTX | TRAX |
|---|---|---|
| Share price | $22.90 | $32.01 |
| Market cap | $1.17B | $1.14B |
| 1-day change | -6.99% | +4.64% |
| YTD return | -0.95% | — |
| 1-year return | -16.12% | — |
| 5-year return | +78.63% | — |
| EPS (TTM) | $-1.27 | $-4.71 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $57.14 | $49.91 |
| 52-week low | $14.78 | $14.72 |
| Distance from 52-week high | -59.92% | -35.86% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +135.28% | +118.68% |
| Average volume | 150.18K | 738.52K |
| Shares outstanding | 50.92M | 35.73M |
| Employees | 100 | 104 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Nanobiotix S.A.
NBTX stock →Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs.
Health Care · Biotechnology: Pharmaceutical Preparations · 100 employees
About First Tracks Biotherapeutics
TRAX stock →First Tracks Biotherapeutics, Inc. operates a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases in United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 104 employees
NBTX vs TRAX FAQ
Which is bigger, Nanobiotix S.A. or First Tracks Biotherapeutics?
Nanobiotix S.A. (NBTX) is larger, with a market capitalization of $1.17B compared with $1.14B for First Tracks Biotherapeutics (TRAX).
Are Nanobiotix S.A. and First Tracks Biotherapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.